Reference
|
Year
|
Country
|
Design
|
Specimens No.
|
Patients No.
|
Age, yr
|
M/F
|
Test
|
Prior treatment
|
Occurrence
|
Gold Standard
|
---|
Meana
|
Median
|
---|
Chen et al. [9]
|
2006
|
US
|
Prospective
|
27
|
30 (27b)
|
–
|
–
|
–
|
PET
|
With or without
|
7 New+ 20 Recur
|
Histo+Radio+follow-up
|
Tripathi et al. [10]
|
2009
|
India
|
Prospective
|
15
|
15
|
28.4 ± 11.1
|
–
|
9/6
|
PET/CT
|
With (Sx/CT/RT) or without
|
3 New+ 12 Recur
|
Histo+Radio+follow-up
|
Sellam et al. [22]
|
2010
|
India
|
Prospective
|
30
|
30
|
–
|
–
|
–
|
PET/CT
|
Sx+/−RT
|
Recur
|
Histo+Radio+follow-up
|
Jora et al. [23]
|
2011
|
India
|
Prospective
|
23
|
23
|
43.25 ± 14.9
|
–
|
–
|
PET/CT
|
15 with (Sx + RT) + 8 without
|
8 New+ 15 Recur
|
Histo+Radio+follow-up
|
Karunanithi et al. [15]
|
2013
|
India
|
Prospective
|
35
|
35
|
36.62 ± 0.86
|
–
|
28/7
|
PET/CT
|
Sx + RT+/−CT
|
Recur
|
Histo+Radio+follow-up
|
Pafundi et al. [24]
|
2013
|
US
|
Prospective
|
23
|
10
|
40.8 ± 18.9
|
–
|
9/1
|
PET/CT
|
With or without
|
8 New+ 2 Recur
|
Histo
|
Herrmann et al. [25]
|
2014
|
US
|
Retrospective
|
110
|
110
|
51.7 ± 12.1
|
52.5
|
72/38
|
PET/CT
|
Sx
|
Recur
|
Histo+Radio+follow-up
|
Moran et al. [26]
|
2015
|
Italy
|
Retrospective
|
27
|
27
|
10
|
10
|
15/12
|
PET
|
1 with (Sx + CT + RT) + 20 without
|
20 New+ 1 Recur
|
Histo+Radio+follow-up
|
Sharma et al. [27]
|
2016
|
India
|
Prospective
|
12
|
11
|
34
|
–
|
6/5
|
PET/CT
|
Sx
|
Recur
|
Histo+Radio+follow-up
|
Paquet et al. [28]
|
2017
|
France
|
Prospective
|
60
|
35
|
60
|
–
|
–
|
PET
|
Sx + CT + RT
|
Recur
|
Histo+Radio
|
Evangelista et al. [29]
|
2018
|
Italy
|
Retrospective
|
13
|
13
|
–
|
60
|
–
|
PET/CT
|
Unclear
|
Recur
|
Radio+follow-up
|
Youland et al. [30]
|
2018
|
US
|
Prospective
|
37
|
13
|
–
|
40
|
9/4
|
PET
|
Sx/CT/RT
|
Recur
|
Histo
|
Evangelista et al. [31]
|
2019
|
Italy
|
Retrospective
|
21
|
21
|
58 ± 11
|
–
|
–
|
PET/CT
|
Sx + CT/RT/immunotherapy
|
Recur
|
Radio+follow-up
|
- M male, F female, New newly-diagnosed, Recur recurrent, Histo histopathology, Radio radiology, Sx surgery, CT chemotherapy, RT radiation therapy
- aMean age is expressed as mean ± standard deviation
- bThree patients with brain metastases were excluded